HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Liver transplant rejection — Clinical Guidelines

Overview

Liver transplant rejection occurs when the recipient's immune system attacks the transplanted organ, compromising its function. This condition requires prompt diagnosis and management to prevent graft loss and maintain patient survival 2.

Diagnosis

Key Diagnostic Criteria: Elevated liver enzymes, abnormal liver biopsy findings, clinical signs of graft dysfunction.

Recommended Tests: Liver biopsy with histopathological evaluation according to the Banff schema for grading 2.

Grading Systems: Utilize the Banff schema for standardized assessment of acute rejection, which may differ from previous systems like the Birmingham criteria 2.

Management

First-Line Treatments: Corticosteroids for acute rejection episodes 3.

Adjunctive Treatments: Adjustment of immunosuppressive regimens, including calcineurin inhibitors, mTOR inhibitors, or induction agents, tailored to individual patient needs 3.

Monitoring: Regular monitoring of immunosuppressive drug levels and renal function to prevent complications like hyperuricemia and renal failure 1.

Special Populations

Renal Function Considerations: Increased vigilance for hyperuricemia and renal failure, particularly in heart transplant recipients, though less prevalent in liver transplant recipients 1.

Key Recommendations

Utilize the Banff schema for grading liver allograft rejection to standardize diagnosis and communication 2 (Evidence: Strong).

Monitor and manage hyperuricemia closely in transplant recipients, given its association with renal complications, especially in heart transplant patients 1 (Evidence: Moderate).

Tailor immunosuppressive therapy based on individual patient response and potential side effects, considering newer agents for safer and more effective management 3 (Evidence: Moderate).

References

1 Shibolet O, Elinav E, Ilan Y, Safadi R, Ashur Y, Eid A et al.. Reduced incidence of hyperuricemia, gout, and renal failure following liver transplantation in comparison to heart transplantation: a long-term follow-up study. Transplantation 2004. link 2 Ormonde DG, de Boer WB, Kierath A, Bell R, Shilkin KB, House AK et al.. Banff schema for grading liver allograft rejection: utility in clinical practice. Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 1999. link 3 Chadha I, Zucker MJ, Mahmood S, Fuzesi L. Immunosuppression: tomorrow and beyond. New Jersey medicine : the journal of the Medical Society of New Jersey 1993. link 4 Zucker K, Lu P, Asthana D, Carreno M, Yang WC, Esquenazi V et al.. Production and characterization of recombinant canine interferon-gamma from Escherichia coli. Journal of interferon research 1993. link 5 Burgio GR. Commentary on the biological self: Toward a "Biological Ego". From Garrod's "chemical individuality" to Burnet's "self". Thymus 1990. link 6 Bruning JW, Claas FH, Kardol MJ, Lansbergen Q, Naipal AM, Tanke HJ. Automated reading of HLA-A,B,C typing and screening. The propidium iodide (PI) method. Human immunology 1982. link90135-5)

Liver transplant rejection